T-cell responses to SARS-CoV-2 in healthy controls and primary immunodeficiency patients
Author(s) -
Arnold Awuah,
Ava Zamani,
Fariba Tahami,
Mark M. Davis,
Louis Grandjean,
Matthew Buckland,
Kimberly Gilmour
Publication year - 2022
Publication title -
clinical and experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1093/cei/uxac001
Subject(s) - immunology , primary immunodeficiency , virology , medicine , immunopathology , covid-19 , biology , immune system , disease , infectious disease (medical specialty) , pathology , outbreak
Understanding the T-cell response to SARS-CoV-2 is key in patients who lack antibody production. We demonstrate the applicability of a functional assay to measure the T-cell response in a cohort of patients with immunodeficiency.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom